South Wales, March 27 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Revolune" on March 16. The details about the trademark application no. UK00004355509 published in the journal no. 2026/013 (March 27).
With Dehns as representative, Carl Zeiss Microscopy GmbH filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Reagents and reagent kits for scientific purposes; biochemical reagents and reagent kits used for non-medical purposes; diagnostic reagents and reagent kits for scientific or research use; all the aforesaid goods for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field.
Class 5 : Clinical diagnostic reagents and reagent kits; medical diagnostic reagents and reagent kits; chemical reagents and reagent kits for medical purposes; biological reagents and reagent kits for medical use; diagnostic reagents and reagent kits for medical use; immunoassay reagents and reagent kits for medical use; diagnostic biomarker reagents and reagent kits for medical purposes; all the aforesaid goods for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field.
Class 9 : Software for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; software for image analysis and processing; software for microscopy.
Class 42 : Development, programming and implementation of software for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; development, programming and implementation of software for image analysis and processing; development, programming and implementation of software for microscopy; software as a service [SaaS] for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; software as a service [SaaS] for image analysis and processing; software as a service [SaaS] for microscopy; platform as a service [PaaS] for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; platform as a service [PaaS] for image analysis and processing; platform as a service [PaaS] for microscopy; advisory services for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; advisory services for image analysis and processing; advisory services for microscopy; scientific research services.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004355509
Disclaimer: Curated by HT Syndication.
